CHINA PHARMA HOLDINGS, INC. (CPHI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 6M 12M 18M Q3 '16: 14.8M Q4 '16: 15.6M Q1 '17: 15.2M Q2 '17: 14.6M Q3 '17: 14.6M Q4 '17: 13.2M Q1 '18: 13.5M Q2 '18: 13.8M Q3 '18: 12.9M Q4 '18: 12.3M Q1 '19: 11.6M Q2 '19: 11M Q3 '19: 11.1M Q4 '19: 10.9M Q1 '20: 9.8M Q2 '20: 11M Q3 '20: 11M Q4 '20: 10.9M Q1 '21: 11.5M Q2 '21: 10.1M Q3 '21: 9.7M Q4 '21: 9.6M Q1 '22: 8.9M Q2 '22: 8.1M Q3 '22: 8.1M Q4 '22: 8.1M Q1 '23: 8.5M Q2 '23: 7.9M Q3 '23: 7.8M Q4 '23: 7M Q1 '24: 6.4M Q2 '24: 6.2M Q3 '24: 5.5M Q4 '24: 4.5M Q1 '25: 4.3M Q2 '25: 4.4M Q3 '25: 4.1M Q4 '25: 4.1M Q1 '26: 4M Q2 '26: 3.9M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

-3M -1.5M 0 1.5M 3M 4.5M Q3 '14: 3.3M Q4 '15: 1.5M Q1 '16: 1M Q2 '16: 1.6M Q3 '16: 1.6M Q4 '16: 3.2M Q1 '17: 3.3M Q2 '17: 3.5M Q3 '17: 3.5M Q4 '17: 2.5M Q1 '18: 2.8M Q2 '18: 2.7M Q3 '18: 2.8M Q4 '19: 1.5M Q1 '20: 1M Q2 '20: 2M Q3 '20: 1.7M Q4 '20: 2M Q1 '21: 2M Q2 '21: 952.4K Q3 '21: 608.8K Q4 '21: 349.3K Q1 '22: -92.9K Q2 '22: -393.3K Q3 '22: -234.7K Q4 '22: -493.9K Q1 '23: -146.5K Q2 '23: -63.8K Q3 '23: -159.2K Q4 '23: -281.1K Q1 '24: -749K Q2 '24: -1.6M Q3 '24: -1.9M Q4 '24: -2M Q1 '25: -1.8M Q2 '25: -903.3K Q3 '25: -443.3K Q4 '25: -131.9K Q1 '26: 289.6K Q2 '26: 460.2K Q3 '16 Q4 '17 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income TTM

-24M -16M -8M 0 8M 16M 24M Q3 '16: -11.1M Q4 '16: -8.2M Q1 '17: -7.6M Q2 '17: -7.5M Q3 '17: -8.1M Q4 '17: -18.7M Q1 '18: -18M Q2 '18: -16.8M Q3 '18: -16.6M Q4 '18: -10.4M Q1 '19: -10.6M Q2 '19: -10.5M Q3 '19: -9.2M Q4 '19: -20.4M Q1 '20: -20.7M Q2 '20: -19.8M Q3 '20: -20.2M Q4 '20: -2.6M Q1 '21: -2.7M Q2 '21: -3.5M Q3 '21: -3.3M Q4 '21: -2.9M Q1 '22: -3.1M Q2 '22: -3.1M Q3 '22: -3M Q4 '22: -3.5M Q1 '23: -3M Q2 '23: -2.7M Q3 '23: -2.7M Q4 '23: -2.8M Q1 '24: -3.3M Q2 '24: -4.2M Q3 '24: -4.6M Q4 '24: -4.6M Q1 '25: -4.4M Q2 '25: -3.7M Q3 '25: -3.2M Q4 '25: -3.2M Q1 '26: -3.6M Q2 '26: -4.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-24M -16M -8M 0 8M 16M 24M Q3 '16: -12M Q4 '16: -9.2M Q1 '17: -8.6M Q2 '17: -8.4M Q3 '17: -8.9M Q4 '17: -19.3M Q1 '18: -18.6M Q2 '18: -17.3M Q3 '18: -17M Q4 '18: -10.8M Q1 '19: -10.9M Q2 '19: -10.7M Q3 '19: -9.5M Q4 '19: -20.7M Q1 '20: -20.9M Q2 '20: -20.1M Q3 '20: -20.4M Q4 '20: -2.9M Q1 '21: -3M Q2 '21: -3.8M Q3 '21: -3.6M Q4 '21: -3.4M Q1 '22: -3.7M Q2 '22: -3.7M Q3 '22: -3.7M Q4 '22: -4M Q1 '23: -3.4M Q2 '23: -3.1M Q3 '23: -3.1M Q4 '23: -3.1M Q1 '24: -3.6M Q2 '24: -4.4M Q3 '24: -4.7M Q4 '24: -4.7M Q1 '25: -4.6M Q2 '25: -3.7M Q3 '25: -3.2M Q4 '25: -3.2M Q1 '26: -3.5M Q2 '26: -4.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 5M 10M 15M Q3 '16: 11.9M Q4 '16: 12.4M Q1 '17: 11.9M Q2 '17: 11.1M Q3 '17: 11.1M Q4 '17: 10.7M Q1 '18: 10.7M Q2 '18: 11.1M Q3 '18: 10.1M Q4 '18: 10.4M Q1 '19: 10.1M Q2 '19: 9.9M Q3 '19: 10.1M Q4 '19: 9.4M Q1 '20: 8.7M Q2 '20: 9M Q3 '20: 9.3M Q4 '20: 8.9M Q1 '21: 9.4M Q2 '21: 9.2M Q3 '21: 9.1M Q4 '21: 9.3M Q1 '22: 9M Q2 '22: 8.5M Q3 '22: 8.3M Q4 '22: 8.6M Q1 '23: 8.6M Q2 '23: 8M Q3 '23: 7.9M Q4 '23: 7.3M Q1 '24: 7.2M Q2 '24: 7.9M Q3 '24: 7.4M Q4 '24: 6.5M Q1 '25: 6.1M Q2 '25: 5.3M Q3 '25: 4.5M Q4 '25: 4.3M Q1 '26: 3.7M Q2 '26: 3.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow TTM

-2M 0 2M 4M 6M Q3 '15: 4.2M Q4 '15: 3.4M Q1 '16: 4.7M Q2 '16: 4.4M Q3 '16: 4.1M Q4 '16: 2.9M Q1 '17: 1.6M Q2 '17: 1.6M Q3 '17: 1.4M Q4 '17: 841.2K Q1 '18: 1.4M Q2 '18: 1.7M Q3 '18: 1.9M Q4 '18: 1.9M Q1 '19: 1.1M Q2 '19: 1.9M Q3 '19: 1.5M Q4 '19: 608.3K Q1 '20: 600.6K Q2 '20: 305.4K Q3 '20: -399.2K Q4 '20: -42.3K Q1 '21: -75K Q2 '21: 509.6K Q3 '21: 283.1K Q4 '21: -249.8K Q1 '22: -852.4K Q2 '22: -1.9M Q3 '22: -1.2M Q4 '22: -409.5K Q1 '23: -998.3K Q2 '23: -880.9K Q3 '23: -92.8K Q4 '23: -699.7K Q1 '24: 183.4K Q2 '24: 327.1K Q3 '24: -727.2K Q4 '25: 148.3K Q1 '26: 166.6K Q2 '26: -140.5K Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '26

Free Cash Flow TTM

-21M -14M -7M 0 7M 14M 21M Q4 '11: 4.9M Q1 '12: 4M Q2 '12: 3.3M Q3 '12: 2.6M Q4 '12: 3.5M Q1 '13: 2.9M Q2 '13: 4.7M Q3 '13: -4.8M Q4 '13: -10.2M Q1 '14: -7.5M Q2 '14: -10.8M Q3 '14: -20.6M Q4 '14: 1M Q1 '15: -1.5M Q2 '15: -2.2M Q3 '15: -1.2M Q4 '15: 2.7M Q1 '16: 3.9M Q2 '16: 3.5M Q3 '16: 3.2M Q4 '16: 2.7M Q1 '17: 1.3M Q2 '17: 1.4M Q3 '17: 1.2M Q4 '17: 704.7K Q1 '18: 1.2M Q2 '18: 1.6M Q3 '18: 1.8M Q4 '18: 1.8M Q1 '19: 1M Q2 '19: 1.8M Q3 '19: 1.4M Q4 '19: 472.3K Q1 '20: 190.7K Q2 '20: -597.5K Q3 '20: -1.5M Q2 '22: -2.5M Q3 '22: -1.6M Q4 '25: 88.9K Q3 '12 Q4 '13 Q1 '15 Q2 '16 Q3 '17 Q4 '18 Q1 '20 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q3 '11: 43.5M Q1 '12: 43.5M Q2 '12: 43.6M Q3 '12: 43.6M Q1 '13: 43.6M Q2 '13: 43.6M Q1 '15: 43.6M Q2 '15: 43.6M Q3 '15: 43.6M Q1 '16: 43.6M Q2 '16: 43.6M Q3 '16: 43.6M Q1 '21: 45.6M Q2 '21: 45.6M Q3 '21: 46M Q1 '22: 4.7M Q2 '22: 4.8M Q3 '22: 5M Q1 '23: 8.1M Q2 '23: 1.7M Q3 '23: 2.6M Q1 '24: 1.3M Q2 '24: 1.6M Q3 '24: 1.7M Q1 '25: 3.3M Q2 '25: 3.2M Q3 '25: 3.9M Q1 '26: 25.6M Q2 '26: 40.5M Q3 '11 Q1 '13 Q3 '15 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q3 '16: -0.28 Q4 '16: -0.22 Q1 '17: -0.20 Q2 '17: -0.19 Q3 '17: -0.20 Q4 '17: -0.43 Q1 '18: -0.42 Q2 '18: -0.39 Q3 '18: -0.38 Q4 '18: -0.25 Q1 '19: -0.25 Q2 '19: -0.25 Q3 '19: -0.23 Q4 '19: -0.49 Q1 '20: -0.50 Q2 '20: -0.48 Q3 '20: -0.48 Q4 '20: -0.07 Q1 '21: -0.07 Q2 '21: -0.09 Q3 '21: -0.09 Q4 '21: -0.75 Q1 '22: -0.95 Q2 '22: -1.11 Q3 '22: -1.25 Q4 '22: -3.78 Q1 '23: -3.62 Q2 '23: -3.79 Q3 '23: -3.92 Q4 '23: -0.72 Q1 '24: -1.38 Q2 '24: -1.92 Q3 '24: -2.28 Q4 '24: -2.72 Q1 '25: -2.24 Q2 '25: -1.51 Q3 '25: -1.03 Q4 '25: -0.74 Q1 '26: -0.54 Q2 '26: -0.42 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.